Burden Ethnographic Modeling Evaluation Qaujilisaaqtuq (BEMEQ) RSV: The Nunavut and Nunavik burden study

Regions: North Slave Region

Tags: health, infants, pandemic, hospitalization, respiratory infection

Principal Investigator: Goldfarb, David (3)
Licence Number: 16813
Organization: University of British Columbia (UBC)
Licensed Year(s): 2021
Issued: Apr 27, 2021
Project Team: Michelle Dittrick, Mai-Lei (Maggie) Kinshella, Darcy Scott,

Objective(s): To determine the rate and outcome of infant respiratory infection hospitalizations; to assess the effectiveness of the palivizumab vaccination program in preventing hospital admissions due (respiratory syncytial virus) RSV infections in Nunavut; understand the factors associated with severe hospital stays due to respiratory tract infections; and assess the potential indirect impact of the COVID-19 pandemic measures on burden of infant admissions to hospital for respiratory infections.

Project Description: This licence has been issued for the scientific research application No.4873. The research team propose to identify the respiratory infection admissions at all hospitals serving Nunavummiut children under one year of age from 2010-2020. The objectives of the study are to 1) determine the rate and outcome of infant respiratory infection hospitalizations; 2) assess the effectiveness of the palivizumab vaccination program in preventing hospital admissions due RSV infections in Nunavut; 3) understand the factors associated with severe hospital stays due to respiratory tract infections; and, 4) assess the potential indirect impact of the COVID-19 pandemic measures on burden of infant admissions to hospital for respiratory infections. The research team will review hospital charts at the six hospitals serving the population of Nunavut: Qikiqtani General Hospital (QGH), Stanton Territorial Hospital (STH), Montreal Children’s Hospital (MCH), Children’s Hospital of Eastern Ontario (CHEO), Winnipeg Children’s Hospital (WCH), and Stollery Children’s Hospital (SCH) in Edmonton. The team will engage public health, clinical and community partners in Nunavut and Northwest Territories throughout the research to identify appropriate ways to inform communities about the project and its outcomes. Methods of sharing results include dissemination teleconferences and a policy brief one pager. The fieldwork for this study will be conducted from April 28, 2021 to December 31, 2021.